News & Updates
Showing Obstetrics & Gynaecology articles
Showing
Show Multimedia Only

Nonhormonal drug for hot flash scores big in two phase III trials
02 Nov 2024
byJairia Dela Cruz
The novel neurokinin-1 and -3 receptor antagonist elinzanetant appears to reduce the frequency and severity of vasomotor symptoms (VMS), as well as improve sleep and menopause-related quality of life, as shown in two pivotal phase III trials.
02 Nov 2024








